Doxycycline Hyclate Tablets — Class II drug recall D-1026-2018
Terminated recall by MAJOR PHARMACEUTICALS, reported 2018-08-08, distributed nationwide. Failed Dissolution Specifications
| Recall number | D-1026-2018 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | MAJOR PHARMACEUTICALS, Livonia, MI, United States |
| Recall initiated | 2018-07-30 |
| Classified | 2018-08-02 |
| Reported by FDA | 2018-08-08 |
| Terminated | 2019-12-02 |
| Distributed | Nationwide (US) |
| Quantity | 3,161 cartons |
| Reason classes | specification failure |
| NDC | 00904-0430, 00904-0430-04, 00904-0430-06, 00904-0430-95 |
| Lot numbers | 71545AA |
| Expiration dates | 2019-07 |
Product
Doxycycline Hyclate Tablets, USP, 100 mg, Rx Only, 30 tablets, 3 x 10 unit dose Cartons, Mfd. by: West-Ward Pharmaceuticals Corp., Eatontown, NY 07724; Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152 USA. NDC: 0904-0430-04
Reason for recall
Failed Dissolution Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1026-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.